NDC 39892-0830-01 - MediChoice Triple Antibiotic
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 39892-0830
- Requested NDC
- 39892-0830-01
- Package NDCs from labels
- 39892-0830-1, 39892-0830-01
- Manufacturer
- O&M HALYARD, INC. | Owens & Minor, Inc
- Effective date
- 2025-10-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MediChoice Triple Antibiotic - O&M HALYARD, INC. | Owens & Minor, Inc | O&M HALYARD, INC. | Owens & Minor, Inc | 2025-10-09 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 39892-0830-1 | MediChoice Triple Antibiotic | 144 in 1 CARTON | OINTMENT | 144 | 6 | |
| 39892-0830-1 | MediChoice Triple Antibiotic | 0.9 g in 1 PACKET | OINTMENT | 0.9 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 39892-0830 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20231210_8369f399-6f64-4441-be72-1f16c7306c0a.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BACITRACIN | ACTIVE INGREDIENT | 58H6RWO52I | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| NEOMYCIN SULFATE | ACTIVE INGREDIENT | 057Y626693 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| POLYMYXIN B SULFATE | ACTIVE INGREDIENT | 19371312D4 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| BACITRACIN | ACTIVE MOIETY | 58H6RWO52I | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| NEOMYCIN | ACTIVE MOIETY | I16QD7X297 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| POLYMYXIN B | ACTIVE MOIETY | J2VZ07J96K | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bactine Max Antibiotic and Lidocaine Max Pain Relief | LIDOCAINE | WellSpring Pharmaceutical Corporation | 71300df9-6113-4f25-93ca-28ad7e7f79de | 2023-06-08 | Warnings | 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | Bausch & Lomb Incorporated | 4456d10b-9995-4430-b692-a8859ea36deb | 2023-06-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | Proficient Rx LP | 21c9b34c-af88-4c9e-9b6c-32d78d34ba7e | 2023-05-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC | A-S Medication Solutions | c895676f-446a-4a93-a3d2-addcce96b108 | 2023-01-23 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Polymyxin B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 72dd6de6-31d6-4a8f-881b-91af91ed9314 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Neomycin Sulfate | NEOMYCIN SULFATE | Teva Pharmaceuticals USA, Inc. | 777dbfab-f83e-4738-ae1e-78619a9f82a7 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | 057Y626693 |
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Proficient Rx LP | 548089f3-29d8-4ba8-af21-9e04356ac29c | 2022-10-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | f5ef71ae-fca9-4a57-ae88-f2b2d195a179 | 2022-08-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| BHI Skin | BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR | MediNatura Inc | 70ab2931-bd2d-43de-bb36-d019f78e3d73 | 2022-07-07 | Warnings | 4T6H12BN9U |
| REFRESH P.M. | MINERAL OIL, PETROLATUM | Allergan, Inc. | 24365d64-cd94-41cc-a7e1-033102d98114 | 2022-06-30 | Warnings | 4T6H12BN9U |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 98042cef-2839-49d6-a7bd-a1d29c74430b | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 601cab21-c211-4c34-be7b-f4fdd97a921a | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Polymyxin B | POLYMYXIN B SULFATE | Hikma Pharmaceuticals USA Inc. | 18daf0d1-b6f5-46f4-ab2f-01a594f3959c | 2022-04-28 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM | Proficient Rx LP | 1252b997-3a81-4f3c-90e4-92f29ba15713 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | Proficient Rx LP | d1f55327-156f-44cd-b0fc-b1a938e8aa73 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
| Cuadriderma | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, AND PRAMOXINE HYDROCHLORIDE | ProMex LLC | 4fa99b96-ab4b-4523-82bc-343dbaf39fb6 | 2022-01-25 | Warnings | M004 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Sandoz Inc | 96a7b0a5-030a-42dc-80cd-35c4e9aa1b6d | 2021-08-31 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Sandoz Inc. | 99d9030f-9118-412c-a377-d1df1c8fa723 | 2021-08-31 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 704a41f5-b109-4c16-8d3e-1495c9917952 | 2021-05-31 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | fbc12c18-567b-41bc-89d0-efd29616615c | 2021-02-28 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.